KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Humana (HUM) Cash & Current Investments (2016 - 2025)

Humana (HUM) has disclosed Cash & Current Investments for 16 consecutive years, with $15.7 billion as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Current Investments changed N/A to $15.7 billion in Q4 2025 year-over-year; TTM through Sep 2025 was $22.1 billion, a N/A change, with the full-year FY2025 number at $15.7 billion, changed N/A from a year prior.
  • Cash & Current Investments was $15.7 billion for Q4 2025 at Humana, down from $22.1 billion in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $26.7 billion in Q3 2022 to a low of $13.7 billion in Q1 2023.
  • A 4-year average of $18.5 billion and a median of $18.0 billion in 2022 define the central range for Cash & Current Investments.
  • Peak YoY movement for Cash & Current Investments: soared 125.71% in 2021, then tumbled 43.23% in 2023.
  • Humana's Cash & Current Investments stood at $16.6 billion in 2021, then increased by 14.2% to $18.9 billion in 2022, then fell by 20.03% to $15.1 billion in 2023, then increased by 3.66% to $15.7 billion in 2025.
  • Per Business Quant, the three most recent readings for HUM's Cash & Current Investments are $15.7 billion (Q4 2025), $22.1 billion (Q3 2025), and $21.7 billion (Q2 2025).